Upgrade your membership to see all of the expert analysis we have published on MED now!
Slumping After 50 Day Moving Average Acted as Resistance - Friday, July 16, 2021
Medifast Inc (MED -$8.33 or -3.04% to $265.27) slumped further below its 50-day moving average (DMA) line which acted as resistance in recent weeks. It will be dropped from the Featured Stocks list tonight. A rebound above its 50 DMA line is needed for its outlook to improve. More damaging losses below the prior low ($258.77 on 6/17/21) would raise greater concerns and trigger a worrisome technical sell signal.MED was highlighted in yellow in the 5/11/21 mid-day report (read here) with pivot point cited based on its 2/16/21 high plus 10 cents. It was shown in this FSU section that evening with an annotated graph under the headline, "Halted 10-Session Losing Streak Near Prior High and 50 DMA".
Recently it reported Mar '21 quarterly earnings +79% on +91% sales revenues versus the year ago period, marking its 3rd consecutive quarterly comparison above the +25% minimum guideline (C criteria), helping it better match with winning models of the fact-based investment system. Annual earnings (A criteria) history has been strong.
The Cosmetics - Personal Care firm has only 11.8 million shares outstanding (S criteria) which can contribute to greater price volatility in the event of institutional buying or selling. The number of top-rated funds owning its shares rose from 425 in Jun '20 to 561 in Jun '21, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 0.9 is an unbiased indication its shares have been under slight distributional pressure over the past 50 days.
Halted 10-Session Losing Streak Near Prior High and 50 DMA - Tuesday, June 15, 2021
Medifast Inc (MED +$2.21 or +0.79% to $282.18) halted its slide with a gain today after 10 consecutive losses with near average volume. Its color code was changed to yellow while testing the prior high in the $279 area which defines initial support to watch above its 50-day moving average (DMA) line ($272). More damaging losses would raise greater concerns.MED was highlighted in yellow in the 5/11/21 mid-day report (read here) with pivot point cited based on its 2/16/21 high plus 10 cents. It was shown in this FSU section that evening with an annotated graph under the headline, "Held Ground Following Breakout Gain on Prior Session"
Recently it reported Mar '21 quarterly earnings +79% on +91% sales revenues versus the year ago period, marking its 3rd consecutive quarterly comparison above the +25% minimum guideline (C criteria), helping it better match with winning models of the fact-based investment system. Annual earnings (A criteria) history has been strong.
Recently it reported Mar '21 quarterly earnings +79% on +91% sales revenues versus the year ago period, marking its 3rd consecutive quarterly comparison above the +25% minimum guideline (C criteria), helping it better match with winning models of the fact-based investment system. Annual earnings (A criteria) history has been strong.
The Cosmetics - Personal Care firm has only 11.8 million shares outstanding (S criteria) which can contribute to greater price volatility in the event of institutional buying or selling. The number of top-rated funds owning its shares rose from 425 in Jun '20 to 540 in Mar '21, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.1 is an unbiased indication its shares have been under accumulation over the past 50 days.
Held Ground Following Breakout Gain on Prior Session - Tuesday, May 11, 2021
Medifast Inc (MED -$0.63 or -0.21% to $294.21) held its ground today after highlighted in yellow in the earlier mid-day report (read here) with pivot point cited based on its 2/16/21 high plus 10 cents. It just powered to new 52-week highs with 4 consecutive volume-driven gains and faces no resistance due to overhead supply. It triggered a technical buy signal on the prior session with a big gain backed by +121% above average volume.Recently it reported Mar '21 quarterly earnings +79% on +91% sales revenues versus the year ago period, marking its 3rd consecutive quarterly comparison above the +25% minimum guideline (C criteria), helping it better match with winning models of the fact-based investment system. Annual earnings (A criteria) history has been strong.
The Cosmetics - Personal Care firm has only 11.8 million shares outstanding )S criteria) which can contribute to greater price volatility in the event of institutional buying or selling. The number of top-rated funds owning its shares rose from 425 in Jun '20 to 529 in Mar '21, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.4 is an unbiased indication its shares have been under accumulation over the past 50 days.
